RemedyRepack Inc. recalls Duloxetine Delayed-Release Capsules
- Published
- 1 Jan 2025
- Units affected
- a) 1,564 cards, b) 799 bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA
- Brand / company
- RemedyRepack Inc.
- Codes / lots
- a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025
- Distribution
- Nationwide in the US
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 1 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.